Open access
Aug 2026
Ligustilide and tectoridin from Danggui Buxue Decoction synergistically attenuate atherosclerosis by targeting the CD36/TRPM2 axis and TNF-α/NF-κB pathway.
This study successfully identified Ligustilide and Tectoridin as the primary bioactive constituents of DBD against atherosclerosis by modulating CD36, TRPM2, and TNF-α, offering a novel pharmacological perspective on the anti-AS efficacy of DBD.
Xin Li, Shui-Hong Zheng, Yu-Qiong Song et al.
· Phytomedicine · 0 citations